BUY Info Edge (India) Limited — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Intraday)1 Sept 2026, 11:07 am ISTvia CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Info Edge shareholders approve ₹3.60 final dividend for FY26
NewsGoogle News·26 Aug · 5d ago
Info Edge Limited Approves the Final Dividend for the Fiscal Year 2026
NewsGoogle News·26 Aug · 5d ago
Info Edge FY26 Results: Revenue rises 15% to ₹30,520 million
NewsGoogle News·25 Aug · 6d ago
Info Edge Subsidiary Redstart To Sell SkyServe Stake For USD 55.55 Million
NewsGoogle News·27 Aug · 4d ago
Info Edge completes Skyserve disinvestment via $55.55 stake repurchase
NewsGoogle News·27 Aug · 4d ago
Info Edge: Sells Entire Stake in SkyServe for USD 55.55 Million
NewsGoogle News·27 Aug · 4d ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Info Edge (India)
- BUY — Akshay Bhagwat, JM Financial19 Oct 2026 · ~2 weeks · target ₹1,300 · Active
- BUY — Prakash Gaba19 Oct 2026 · Same day · target ₹1,280 · SL hit
- BUY — Ansh Jogendra Bhilwar19 Oct 2026 · ~2 weeks · target ₹1,312 · SL hit
- BUY — Rakesh Bansal16 Oct 2026 · ~2 weeks · target ₹1,385 · SL hit
- BUY — Osho Krishan, Angel One16 Oct 2026 · ~2 weeks · target ₹1,290 · SL hit
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

